Major Ivermectin Study Omitted Hundreds of Participants, Researchers Say
By Zachary Stieber A large study examining ivermectin against COVID-19 included more participants than was reported in 2023, researchers acknowledged in a new correction. A U.S. government-funded trial arm examining ivermectin was said to have included 1,206 participants, including 602 who received ivermectin. The actual number of participants was 1,432, with 708 receiving ivermectin, Dr.
More Stories
Sernova (OTCMKTS:SEOVF) Releases Earnings Results
Sernova (OTCMKTS:SEOVF – Get Free Report) posted its earnings results on Monday. The company reported ($0.01) EPS for the quarter,...
GoviEx Uranium (CVE:GXU) Stock Price Down 18.2% – What’s Next?
Shares of GoviEx Uranium Inc. (CVE:GXU – Get Free Report) traded down 18.2% during mid-day trading on Monday . The...
Nordstrom to Go Private in $6.25 Billion Deal
By Austin Alonzo American luxury department store chain Nordstrom will be taken private in a $6.25 billion deal, according to...
Former President Bill Clinton Hospitalized With Fever, Spokesperson Says
By Jack Phillips Former President Bill Clinton was checked into a Washington hospital on Monday after developing a fever, said...
Cosmos Health (NASDAQ:COSM) vs. Aceto (OTCMKTS:ACETQ) Head to Head Analysis
Aceto (OTCMKTS:ACETQ – Get Free Report) and Cosmos Health (NASDAQ:COSM – Get Free Report) are both small-cap medical companies, but...
Invesco Dorsey Wright Utilities Momentum ETF (NASDAQ:PUI) Plans Dividend of $0.20
Invesco Dorsey Wright Utilities Momentum ETF (NASDAQ:PUI – Get Free Report) announced a dividend on Monday, December 23rd,NASDAQ Dividends reports....